These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 33216779)

  • 1. Health outcomes and experiences of direct-to-consumer high-intensity screening using both whole-body magnetic resonance imaging and cardiological examination.
    Hommes D; Klatte D; Otten W; Beltman M; Klass G; Zand A; Sprangers R
    PLoS One; 2020; 15(11):e0242066. PubMed ID: 33216779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole-body magnetic resonance imaging (WB-MRI) for cancer screening in asymptomatic subjects of the general population: review and recommendations.
    Zugni F; Padhani AR; Koh DM; Summers PE; Bellomi M; Petralia G
    Cancer Imaging; 2020 May; 20(1):34. PubMed ID: 32393345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility of whole-body MRI for cancer screening in children and young people with ataxia telangiectasia: A mixed methods cross-sectional study.
    Neves R; Panek R; Clarkson K; Panagioti O; Fernandez NS; Wilne S; Suri M; Whitehouse WP; Jagani S; Dandapani M; Glazebrook C; Dineen RA
    Cancer Med; 2024 Jul; 13(14):e70049. PubMed ID: 39056567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-body magnetic resonance imaging of healthy volunteers: pilot study results from the population-based SHIP study.
    Hegenscheid K; Kühn JP; Völzke H; Biffar R; Hosten N; Puls R
    Rofo; 2009 Aug; 181(8):748-59. PubMed ID: 19598074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of functional cardiac testing in the diagnosis and management of coronary artery disease: a randomised controlled trial. The CECaT trial.
    Sharples L; Hughes V; Crean A; Dyer M; Buxton M; Goldsmith K; Stone D
    Health Technol Assess; 2007 Dec; 11(49):iii-iv, ix-115. PubMed ID: 18021576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-body magnetic resonance imaging as surveillance for subsequent malignancies in preadolescent, adolescent, and young adult survivors of germline retinoblastoma: An update.
    Friedman DN; Hsu M; Moskowitz CS; Francis JH; Lis E; Fleischut MH; Oeffinger KC; Walsh M; Tonorezos ES; Sklar CA; Abramson DH; Dunkel IJ
    Pediatr Blood Cancer; 2020 Jul; 67(7):e28389. PubMed ID: 32386119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnostic value of whole-body MRI and bone scintigraphy in the detection of osseous metastases in patients with breast cancer--A Prospective Double-Blinded Study at two Hospital Centers].
    Ohlmann-Knafo S; Kirschbaum M; Fenzl G; Pickuth D
    Rofo; 2009 Mar; 181(3):255-63. PubMed ID: 19229791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
    Schmidt GP; Kramer H; Reiser MF; Glaser C
    Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole body MRI, including diffusion-weighted imaging in follow-up of patients with testicular cancer.
    Mosavi F; Laurell A; Ahlström H
    Acta Oncol; 2015 Nov; 54(10):1763-9. PubMed ID: 25975210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary observations regarding the expectations, acceptability and satisfaction of whole-body MRI in self-referring asymptomatic subjects.
    Busacchio D; Mazzocco K; Gandini S; Pricolo P; Masiero M; Summers PE; Pravettoni G; Petralia G
    Br J Radiol; 2021 Feb; 94(1118):20191031. PubMed ID: 33237810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole body magnetic resonance imaging (WB-MRI) and brain MRI baseline surveillance in TP53 germline mutation carriers: experience from the Li-Fraumeni Syndrome Education and Early Detection (LEAD) clinic.
    Bojadzieva J; Amini B; Day SF; Jackson TL; Thomas PS; Willis BJ; Throckmorton WR; Daw NC; Bevers TB; Strong LC
    Fam Cancer; 2018 Apr; 17(2):287-294. PubMed ID: 28988289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychosocial consequences and severity of disclosed incidental findings from whole-body MRI in a general population study.
    Schmidt CO; Hegenscheid K; Erdmann P; Kohlmann T; Langanke M; Völzke H; Puls R; Assel H; Biffar R; Grabe HJ
    Eur Radiol; 2013 May; 23(5):1343-51. PubMed ID: 23239059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Staging of colon cancer: whole-body MRI vs. whole-body PET-CT--initial clinical experience.
    Squillaci E; Manenti G; Mancino S; Cicciò C; Calabria F; Danieli R; Schillaci O; Simonetti G
    Abdom Imaging; 2008; 33(6):676-88. PubMed ID: 18373114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous positron emission tomography/magnetic resonance imaging for whole-body staging in patients with recurrent gynecological malignancies of the pelvis: a comparison to whole-body magnetic resonance imaging alone.
    Grueneisen J; Beiderwellen K; Heusch P; Gratz M; Schulze-Hagen A; Heubner M; Kinner S; Forsting M; Lauenstein T; Ruhlmann V; Umutlu L
    Invest Radiol; 2014 Dec; 49(12):808-15. PubMed ID: 25010207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The addition of whole-body magnetic resonance imaging to body computerised tomography alters treatment decisions in patients with metastatic breast cancer.
    Kosmin M; Makris A; Joshi PV; Ah-See ML; Woolf D; Padhani AR
    Eur J Cancer; 2017 May; 77():109-116. PubMed ID: 28390297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-body MRI for preventive health screening: Management strategies and clinical implications.
    Basar Y; Alis D; Tekcan Sanli DE; Akbas T; Karaarslan E
    Eur J Radiol; 2021 Apr; 137():109584. PubMed ID: 33596499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole-body-MR imaging including DWIBS in the work-up of patients with head and neck squamous cell carcinoma: a feasibility study.
    Noij DP; Boerhout EJ; Pieters-van den Bos IC; Comans EF; Oprea-Lager D; Reinhard R; Hoekstra OS; de Bree R; de Graaf P; Castelijns JA
    Eur J Radiol; 2014 Jul; 83(7):1144-1151. PubMed ID: 24768188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How to report incidental findings from population whole-body MRI: view of participants of the German National Cohort.
    Hegedüs P; von Stackelberg O; Neumann C; Selder S; Werner N; Erdmann P; Granitza A; Völzke H; Bamberg F; Kaaks R; Bertheau RC; Kauczor HU; Schlett CL; Weckbach S
    Eur Radiol; 2019 Nov; 29(11):5873-5878. PubMed ID: 30915558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-body MRI for the staging and follow-up of patients with metastasis.
    Schmidt GP; Reiser MF; Baur-Melnyk A
    Eur J Radiol; 2009 Jun; 70(3):393-400. PubMed ID: 19457631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychological characteristics and satisfaction for the whole-body MRI in cancer screening.
    Busacchio D; Mazzoni D; Mazzocco K; Pricolo P; Summers PE; Petralia G; Pravettoni G
    Psychol Health Med; 2023 Feb; 28(2):548-554. PubMed ID: 36148490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.